Baird Medical Investment Holdings Ltd income statement

In fiscal 2025, Baird Medical Investment Holdings Ltd reported revenue of $22.5m, down 39.2% on the year before, operating income of −$25.6m (a -113.7% margin) and net income of −$27.3m, or −$0.98 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Baird Medical Investment Holdings Ltd: income statement, annual
Fiscal year	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Revenue	35	31	37	23
Cost of revenue	7	4	4	4
Gross profit	28	27	33	19
Research and development	4	4	6	20
Selling and marketing	4	3	4	10
General and administrative	7	9	7	14
Operating income	14	12	15	−26
Interest expense	0	0	1	1
Income before tax	15	12	14	−26
Income tax	2	2	1	1
Net income	13	11	12	−27
Diluted EPS	$0.49	$0.51	$0.57	−$0.98
Diluted shares (average)	26m	21m	22m	28m
EBITDA	15	13	16	−25

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: BDMD vs SNOA BDMD vs VVOS BDMD vs NEPH BDMD vs QTI

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Baird Medical Investment Holdings Ltd's SEC filings (10-K and 10-Q). How we read and check them: methodology and data sources. Not investment advice. Back to Baird Medical Investment Holdings Ltd.